Form 4: Cumberland Pharmaceuticals Director Kenneth Krogulski Increases Stake Through Pre-Planned Stock Purchases

Director Kenneth Krogulski of Cumberland Pharmaceuticals has been steadily increasing his holdings of company stock through a pre-arranged trading plan.

Summary

• Kenneth Krogulski, a director at Cumberland Pharmaceuticals, has been acquiring shares of the company's common stock.
• These purchases were made automatically under a Rule 10b5-1 trading plan established on March 13, 2024.
• The transactions occurred between December 2, 2024, and December 20, 2024.
• Krogulski purchased a total of 4,801 shares over this period.
• The prices per share ranged from $1.20 to $2.48.
• Following these transactions, Krogulski's total direct holdings increased to 276,343 shares.

Sentiment

Score: 7

Explanation: The document indicates a director is increasing their stake in the company, which is generally a positive sign. The purchases are part of a pre-planned trading plan, so there is no indication of any unexpected news.

Positives

• The director's consistent purchases demonstrate confidence in the company's future.
• The use of a pre-planned trading plan suggests a long-term investment strategy.

Industry Context

This type of filing is common for corporate insiders who are regularly buying or selling shares of their company. It is a standard practice to use a 10b5-1 plan to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan is a common practice among corporate insiders to manage their stock transactions and avoid potential insider trading issues.
• The reported transactions are typical for directors who are increasing their stake in the company.
• The range of prices paid is within the normal fluctuations of the stock price.

Stakeholder Impact

• The increased holdings by a director may be viewed positively by shareholders, indicating confidence in the company's future.

Key Dates

Keywords

Cumberland Pharmaceuticals, stock purchases, insider trading, Rule 10b5-1, Kenneth Krogulski, director, share acquisition